Investor Relations

Savoy’s strategy to market is through the development of its first product, Oncoprev™, for the treatment of liver cancer. Liver cancer is among the most prevalent cancers in the world and kills most patients within 1 year of diagnosis. Pre-clinical test results have shown success in binding to and eliminating cancerous cells. There are no other products on the market currently that come close to these results.